Harvard Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $30.7M | $73.1M | $4.3M |
| FY2024 | $0 | $63.3M | $4.1M |
| FY2025 | $35.9M | $13.7M | $8.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $30.7M | $73.1M | $4.3M |
| FY2024 | $0 | $63.3M | $4.1M |
| FY2025 | $35.9M | $13.7M | $8.6M |